Search results
Results From The WOW.Com Content Network
June 25, 2024 at 3:43 PM. Andre Penner. The Centers for Disease Control and Prevention issued a health advisory Tuesday alerting authorities, health care providers and the public of the increased ...
The most common symptom of dengue is fever (which can range from mild to 104 degrees) and other symptoms, including: Muscle aches and pains. Pain behind the eyes. Bone pain (leading to its common ...
red eyes. Symptoms usually last between 2–7 days, and most people feel better after one week. The fever typically persists for at least 24 hours and may spike again. Between 0.5% and 5% of cases ...
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [ 9] Development of dengue vaccines began in the 1920s, but was hindered by the need to create immunity against all four dengue serotypes. [ 10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [ 11][ 12]
Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic; if symptoms appear they typically begin 3 to 14 days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin itching and skin rash.
An outbreak caused by serotype DENV-1 occurred in 2002 on Easter Island. Subsequent outbreaks occurred in 2006–2007 and 2008, 2009 and 2011 with decreasing magnitude over time. The male:female ratio in reported cases was approximately 1:1 and the average age at infection was 31.38 ± 18.37 in both sexes.
June 26, 2024 at 2:08 PM. Federal health officials issued a warning over the increased risk of dengue fever around the world — with nearly 10 million reported cases this year in the Americas ...
A positive tourniquet test on the right side of a patient with dengue fever. Note the increased number of petechia. A tourniquet test (also known as a Rumpel-Leede capillary-fragility test or simply a capillary fragility test) determines capillary fragility. It is a clinical diagnostic method to determine a patient's haemorrhagic tendency.